Nada Elbuluk, MD, FAAD: Research and Utility of Ruxolitinib Cream for Vitiligo

Shanna Miranti, MPAS, PA-C: Managing the Psychosocial Impact of Vitiligo

Shanna Miranti, MPAS, PA-C, discusses the bimodal distribution of vitiligo in male and female individuals and the necessary counseling for those who are managing their initial diagnosis....

Nada Elbuluk, MD: Connecting Patients with Vitiligo with Supportive Resources

Dr. Elbuluk discusses the importance of connecting patients with vitiligo to supportive resources for preventing and mitigating anxiety and depression related to the condition, especially socioeconomically disadvantaged patients who may not be aware of these resources in their community....

Nada Elbuluk, MD: New Research on Psychological Comorbidities in Patients with Vitiligo

Dr. Elbuluk discusses a recently published retrospective chart review that she and her colleagues published in the Archives of Dermatological Research, which included all patients diagnosed with vitiligo treated at a private hospital and a public hospital over a period of ten years, with a focus on associated psychiatric comorbidities. She summarizes the findings of rates of anxiety and depression in patients with vitiligo in terms of gender, race, and socioeconomic status....

Andrea Nguyen, PA-C, MS: Determining Treatment Goals and Expectations for Patients with Vitiligo

Andrea Nguyen discusses how she counsels patients with vitiligo and emphasizes the importance in communicating with patients about consistent application and dosing during a treatment regimen....

Raj Chovatiya, MD, PhD: Utilizing Ruxolitinib Cream for Patients with Vitiligo

Dr. Chovatiya discusses how to effectively treat patients with nonsegmental vitiligo using topical ruxolitinib cream and the importance in a slow and steady treatment regimen....

EXPERT PERSPECTIVES IN VITILIGO

Experts in the field discuss new therapies and how they will impact a dermatology practice.